Literature DB >> 3122742

Modulation of tumor necrosis factor-alpha cytotoxicity in L929 cells by bacterial toxins, hydrocortisone and inhibitors of arachidonic acid metabolism.

A Hepburn1, J M Boeynaems, W Fiers, J E Dumont.   

Abstract

L929 cells were incubated with tumor necrosis factor-alpha (TNF-alpha) in the presence or absence of various inhibitors of arachidonic acid metabolism. The addition of either hydrocortisone or nordihydroguaiaretic acid (NDGA) decreased the cytotoxic effect of TNF-alpha but exogenously added arachidonate or linoleate, indomethacin and eicosatetraynoic acid (ETYA) were without effect. While it was found that TNF-alpha stimulated arachidonic acid release, no metabolites of this fatty acid could be evidenced. Cytotoxicity of TNF-alpha could also be decreased by the addition of either cholera or pertussis toxin. These results suggest that a GTP-binding protein is involved in the cytotoxic action of TNF-alpha. Arachidonic acid, released possibly by a phospholipase A2, might also play a role, but probably not via its conversion to known metabolites.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3122742     DOI: 10.1016/0006-291x(87)90440-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Involvement of oxidants and oxidant-generating enzyme(s) in tumour-necrosis-factor-alpha-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain.

Authors:  V B O'Donnell; S Spycher; A Azzi
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

2.  Effects of n-3 and n-6 fatty acids on tumor necrosis factor cytotoxicity in WEHI fibrosarcoma cells.

Authors:  O L Brekke; T Espevik; T Bardal; K S Bjerve
Journal:  Lipids       Date:  1992-03       Impact factor: 1.880

3.  Butylated hydroxyanisole inhibits tumor necrosis factor-induced cytotoxicity and arachidonic acid release.

Authors:  O L Brekke; T Espevik; K S Bjerve
Journal:  Lipids       Date:  1994-02       Impact factor: 1.880

4.  The Gβγ-Src signaling pathway regulates TNF-induced necroptosis via control of necrosome translocation.

Authors:  Lisheng Li; Wanze Chen; Yaoji Liang; Huabin Ma; Wenjuan Li; Zhenru Zhou; Jie Li; Yan Ding; Junming Ren; Juan Lin; Felicia Han; Jianfeng Wu; Jiahuai Han
Journal:  Cell Res       Date:  2014-02-11       Impact factor: 25.617

5.  Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases.

Authors:  G Fantuzzi; P Ghezzi
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

6.  Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines.

Authors:  D Eads; Rl Hansen; Ao Oyegunwa; Ce Cecil; Ca Culver; F Scholle; Itd Petty; Sm Laster
Journal:  J Inflamm (Lond)       Date:  2009-01-08       Impact factor: 4.981

7.  TNF induces c-fos via a novel pathway requiring conversion of arachidonic acid to a lipoxygenase metabolite.

Authors:  E M Haliday; C S Ramesha; G Ringold
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

8.  Streptococcal glycoprotein-induced tumour cell growth inhibition involves the modulation of a pertussis toxin-sensitive G protein.

Authors:  J Yoshida; S Takamura; S Suzuki; M Nishio
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.